Coronary Stents - Medical Devices Pipeline Assessment, 2020

Coronary Stents - Medical Devices Pipeline Assessment, 2020

Coronary Stents - Medical Devices Pipeline Assessment, 2020

Summary

GlobalData's Medical Devices sector report, “Coronary Stents - Medical Devices Pipeline Assessment, 2020 provides comprehensive information about the Coronary Stents pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

A stent is an expandable perforated tube that is inserted into a natural conduit of the body to prevent or counteract a disease-induced localized flow constriction.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Coronary Stents under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Coronary Stents and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Coronary Stents under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


  • Introduction
    • Coronary Stents Overview
  • Products under Development
    • Coronary Stents - Pipeline Products by Stage of Development
      • Table Figure 1: Coronary Stents - Pipeline Products by Stage of Development
      • Table Coronary Stents - Pipeline Products by Stage of Development
    • Coronary Stents - Pipeline Products by Segment
      • Table Figure 2: Coronary Stents - Pipeline Products by Segment
      • Table Coronary Stents - Pipeline Products by Segment
    • Coronary Stents - Pipeline Products by Territory
      • Table Figure 3: Coronary Stents - Pipeline Products by Territory
      • Table Coronary Stents - Pipeline Products by Territory
    • Coronary Stents - Pipeline Products by Regulatory Path
      • Table Figure 4: Coronary Stents - Pipeline Products by Regulatory Path
      • Table Coronary Stents - Pipeline Products by Regulatory Path
    • Coronary Stents - Pipeline Products by Estimated Approval Date
      • Table Figure 5: Coronary Stents - Pipeline Products by Estimated Approval Date
      • Table Coronary Stents - Pipeline Products by Estimated Approval Date
    • Coronary Stents - Ongoing Clinical Trials
      • Table Figure 6: Coronary Stents - Ongoing Clinical Trials
      • Table Coronary Stents - Ongoing Clinical Trials
  • Coronary Stents - Pipeline Products under Development by Companies
    • Coronary Stents Companies - Pipeline Products by Stage of Development
      • Table Coronary Stents Companies - Pipeline Products by Stage of Development
    • Coronary Stents – Companies Pipeline Products by Stage of Development
      • Table Coronary Stents – Companies Pipeline Products by Stage of Development
  • Coronary Stents Companies and Product Overview
    • Abbott Vascular Inc Company Overview
      • Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Second Generation Bioresorbable Vascular Scaffold - Product Status
        • Table Second Generation Bioresorbable Vascular Scaffold - Product Description
        • Table Xience SBA Everolimus Eluting Coronary Stent System - Product Status
        • Table Xience SBA Everolimus Eluting Coronary Stent System - Product Description
        • Table XIENCE Thin man DES - Product Status
        • Table XIENCE Thin man DES - Product Description
        • Table ZoMaxx Drug Eluting Coronary Stent System - Product Status
        • Table ZoMaxx Drug Eluting Coronary Stent System - Product Description
        • Table Abbott Vascular Inc - Ongoing Clinical Trials Overview
        • Table Xience SBA Everolimus Eluting Coronary Stent System - A Multi-center, Randomized, Controlled
        • Table Xience SBA Everolimus Eluting Coronary Stent System - A Prospective Global Randomized Trial Assessing the Safety and Efficacy of the BuMA Supreme Biodegradable Drug Coated Coronary Stent System for Coronary Revascularization in Patients with Stable Coronary Artery Disease or Non-ST Segment Elevation Acute Coronary Syndromes
        • Table Xience SBA Everolimus Eluting Coronary Stent System - A Prospective Multicenter Randomized Post Market All-comer Trial to Assess the Safety and Effectiveness of the Supraflex Sirolimus-eluting Coronary Stent System for the Treatment of Atherosclerotic Lesion(s)
        • Table Xience SBA Everolimus Eluting Coronary Stent System - Polish Bifurcation Optimal Treatment Strategy Study for Left Main Bifurcation Percutaneous Coronary Intervention (PCI)
    • Adcomp Technologies Inc. Company Overview
      • Adcomp Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Adcomp Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Dual Drug Eluting Stent - Product Status
        • Table Dual Drug Eluting Stent - Product Description
    • Advanced Bifurcation Systems Inc Company Overview
      • Advanced Bifurcation Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Advanced Bifurcation Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Stenting System - Bare Metal Stent - Product Status
        • Table Stenting System - Bare Metal Stent - Product Description
        • Table Stenting System - Drug Eluting Stent - Product Status
        • Table Stenting System - Drug Eluting Stent - Product Description
    • Aeon Bioscience Company Overview
      • Aeon Bioscience Pipeline Products & Ongoing Clinical Trials Overview
        • Table Aeon Bioscience Pipeline Products & Ongoing Clinical Trials Overview
        • Table Drug Eluting Stent - Product Status(Aeon Bioscience)
        • Table Drug Eluting Stent - Product Description(Aeon Bioscience)
    • AlviMedica Medical Technologies Inc Company Overview
      • AlviMedica Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table AlviMedica Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table BMS - Avantgarde - Product Status
        • Table BMS - Avantgarde - Product Description
        • Table Commander - Product Status
        • Table Commander - Product Description
        • Table Cre8 DES - Product Status
        • Table Cre8 DES - Product Description
        • Table Cre8 EVO DES - Product Status
        • Table Cre8 EVO DES - Product Description
        • Table DES - Coracto - Product Status
        • Table DES - Coracto - Product Description
        • Table Ephesos II - Product Status
        • Table Ephesos II - Product Description
        • Table Inperia Advance - Product Status
        • Table Inperia Advance - Product Description
        • Table AlviMedica Medical Technologies Inc - Ongoing Clinical Trials Overview
        • Table Cre8 DES - A Prospective, Multi-center, Open Label, Randomized Controlled, Two Arm Study Evaluating Safety and Efficacy of the Permanent Polymer Zotarolimus Eluting Stent Resolute Integrity Compared to the Polymer Free Amphilimus Eluting Stent Cre8
        • Table Cre8 DES - A Prospective, Multi-center, Randomized Controlled Trial Evaluating the Safety and Efficacy of the CRE8 Sirolimus-Eluting Stent Versus the RESOLUTE Zotarolimus-eluting Stent in the Treatment of Patients with De Novo Coronary Artery Lesions
        • Table Cre8 DES - A Prospective, Multi-center, Single-arm Observational Registry Trial Evaluating the Safety and Efficacy of CRE8 Sirolimus-Eluting Stent in the Treatment of Patients With De Novo Coronary Artery Lesions
        • Table Cre8 DES - Prove ART (Abluminal Reservoir Technology) Clinical Benefit in Alla Comers Patients
        • Table Cre8 DES - Safety and Performance Assessment of Coronary Drug-eluting Stent CRE8: Postmarket Observational Study
        • Table Cre8 DES - Second-generation Drug-eluting Stents in Diabetes: A Randomized Trial: The SUGAR Trial
        • Table Cre8 EVO DES - Randomized 2x2 Factorial Trial Comparing the Cre8 Amphilimus-sirolimus Eluting Stent versus the Synergy Everolimus-eluting Stent and a Personalized versus Standard Duration of Dual Antiplatelet Therapy in All-comers Patients Undergoing Percutaneous Coronary Intervention
    • Amaranth Medical Inc Company Overview
      • Amaranth Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Amaranth Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table 80-micron MAGNITUDE Bioresorbable Scaffold - Product Status
        • Table 80-micron MAGNITUDE Bioresorbable Scaffold - Product Description
        • Table APTITUDE Sirolimus-Eluting Bioresorbable Scaffold - Product Status
        • Table APTITUDE Sirolimus-Eluting Bioresorbable Scaffold - Product Description
        • Table DEFIANCE Scaffold - Product Status
        • Table DEFIANCE Scaffold - Product Description
        • Table FORTITUDE Scaffold - Product Status
        • Table FORTITUDE Scaffold - Product Description
        • Table MAGNITUDE Sirolimus-Eluting Bioresorbable Scaffold - Product Status
        • Table MAGNITUDE Sirolimus-Eluting Bioresorbable Scaffold - Product Description
        • Table Second Generation FORTITUDE Scaffold - Product Status
        • Table Second Generation FORTITUDE Scaffold - Product Description
        • Table Amaranth Medical Inc - Ongoing Clinical Trials Overview
        • Table FORTITUDE Scaffold - Amaranth Endovascular Study of a Drug-eluting Bioresorbable Coronary Scaffold
        • Table FORTITUDE Scaffold - Restoring Endoluminal Narrowing Using Bioresorbable Scaffolds – European Trial
        • Table APTITUDE Sirolimus-Eluting Bioresorbable Scaffold - Restoring Endoluminal Narrowing Using Bioresorbable Scaffolds - Extended Trial II
        • Table MAGNITUDE Sirolimus-Eluting Bioresorbable Scaffold - Restoring Endoluminal Narrowing Using Bioresorbable Scaffolds - Extended Trial III
    • Arterius Ltd Company Overview
      • Arterius Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Arterius Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Arteriosorb Absorbable Drug-Eluting Scaffold - Product Status
        • Table Arteriosorb Absorbable Drug-Eluting Scaffold - Product Description
    • Atrium Medical Corp Company Overview
      • Atrium Medical Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Atrium Medical Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Next Generation Super Flexible Cobalt Chromium Coronary Stent - Product Status
        • Table Next Generation Super Flexible Cobalt Chromium Coronary Stent - Product Description
    • Axordia Ltd (Inactive) Company Overview
      • Axordia Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Axordia Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Regenerative Stent - Product Status
        • Table Regenerative Stent - Product Description
    • B. Braun Melsungen AG Company Overview
      • B. Braun Melsungen AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table B. Braun Melsungen AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Coroflex DEBlue - Product Status
        • Table Coroflex DEBlue - Product Description
    • Bactiguard Holding AB Company Overview
      • Bactiguard Holding AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bactiguard Holding AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table Metal-Coated Vascular Stent - Product Status
        • Table Metal-Coated Vascular Stent - Product Description
    • Bionext Biotech Products Ltd. Company Overview
      • Bionext Biotech Products Ltd. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bionext Biotech Products Ltd. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biostent - Product Status
        • Table Biostent - Product Description
    • Biosensors International Group Ltd Company Overview
      • Biosensors International Group Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biosensors International Group Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table BioFreedom Drug Coated Stent - Product Status
        • Table BioFreedom Drug Coated Stent - Product Description
        • Table Sparrow Drug Eluting Stent System - Product Status
        • Table Sparrow Drug Eluting Stent System - Product Description
        • Table Biosensors International Group Ltd - Ongoing Clinical Trials Overview
        • Table BioFreedom Drug Coated Stent - A Prospective Study of the BioFreedom Biolimus A9 Drug Coated Stent in Patients at High Risk for Bleeding
        • Table BioFreedom Drug Coated Stent - A Randomized Controlled Comparison Between One Versus More than Six Months of Dual Antiplatelet Therapy after Biolimus A9-eluting Stent Implantation
        • Table BioFreedom Drug Coated Stent - A Study Evaluating the Safety and Efficacy of the BioFreedom Biolimus A9 Coated Cobalt Chromium Coronary Stent System in Patients at High Risk of Bleeding
        • Table BioFreedom Drug Coated Stent - Asian Registry of the BioFreedom BA9 Drug-Coated Coronary Stent for Patients with ST Elevation Myocardial Infarction (STEMI) Undergoing Percutaneous Coronary Intervention (PCI)
        • Table BioFreedom Drug Coated Stent - Evaluation of Effectiveness and Safety of BioFreedom Stent in Routine Clinical Practice: A Multicenter, Prospective Observational Study
        • Table BioFreedom Drug Coated Stent - Evaluation of Effectiveness and Safety of the First, Second, and New Drug-eluting Stents in Routine Clinical Practice
        • Table BioFreedom Drug Coated Stent - Prospective Multicenter Observational Study for Evaluating Efficacy and Safety of Biofreedom Stent in Patients with Coronary Artery Disease: Biofreedom Registry
        • Table BioFreedom Drug Coated Stent - Randomized Comparison of a Polymer-free Biolimus-eluting BioFreedom Stent with a Biodegradable-polymer Sirolimus-eluting Orsiro Stent in Patients Treated with Percutaneous Coronary Intervention
        • Table BioFreedom Drug Coated Stent - Randomized Comparison of Vascular Healing of a Polymer-free Biolimus-eluting BIOFREEDOM Stent with a Biodegradable-polymer Sirolimus-eluting ORSIRO Stent in Patients with ST-segment Elevation Myocardial Infarction
        • Table BioFreedom Drug Coated Stent - Six-month Endothelial and Microvascular Function of the Bioactive Sirolimus-eluting Combo Stent Vs. The Polymer-free Biolimus-eluting Biofreedom Stent in Patients with St-segment Elevation Myocardial Infarction
        • Table BioFreedom Drug Coated Stent - To Collect Additional Safety and Effectiveness Data for the Biosensors BioFreedom BA9 Drug Coated Coronary Stent in Patients with Native, de Novo Coronary Artery Disease
    • Biosten, LLC Company Overview
      • Biosten, LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biosten, LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biodegradable Endovascular Implant - Product Status
        • Table Biodegradable Endovascular Implant - Product Description
    • Biotronik AG Company Overview
      • Biotronik AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biotronik AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Coronary Stent System - Product Status
        • Table Coronary Stent System - Product Description
        • Table DREAMS 3G System - Product Status
        • Table DREAMS 3G System - Product Description
        • Table Magmaris Bioresorbable Magnesium Scaffold - Product Status
        • Table Magmaris Bioresorbable Magnesium Scaffold - Product Description
        • Table Biotronik AG - Ongoing Clinical Trials Overview
        • Table Magmaris Bioresorbable Magnesium Scaffold - A Sirolimus Eluting Bioresorbable Magnesium Stent for Treatment of Coronary Bifurcation Lesions: The BIFSORB Pilot Study II
        • Table Magmaris Bioresorbable Magnesium Scaffold - BIOTRONIK - Safety and Clinical Performance of the Drug Eluting Absorbable Metal Scaffold (DREAMS 2nd Generation) in the Treatment of Subjects with de Novo Lesions in Native Coronary Arteries: BIOSOLVE-II
        • Table Magmaris Bioresorbable Magnesium Scaffold - Biotroniks - Safety and Performance in de Novo Lesion of Native Coronary Arteries with Magmaris- Registry: BIOSOLVE-IV
        • Table Magmaris Bioresorbable Magnesium Scaffold - BIOTRONIKS-Safety and Performance in de Novo Lesion of Native Coronary Arteries with Magmaris (BIOSOLVE)-IV Magmaris Swiss Satellite Registry
        • Table Magmaris Bioresorbable Magnesium Scaffold - Coronary Artery Healing Process after Bioresorbable Scaffold in Patients with Non-ST-segment Elevation Myocardial Infarction (NSTEMI)
        • Table Magmaris Bioresorbable Magnesium Scaffold - Optical Coherence Guided Treatment of Stsegment Elevation Myocardial Infarction with the Drug-eluting Resorbable Magnesium Scaffold: The BEST- MAG Multicentre Study (Belgian ST-segment Elevation Myocardial Infarction Treatment with Resorbable Magnesium Scaffold)
        • Table Magmaris Bioresorbable Magnesium Scaffold - Prospective Observational Registry of Patients with a Bioabsorbable Magnesium Stent Implant -MAGMARIS- in Usual Clinical Practice
        • Table Magmaris Bioresorbable Magnesium Scaffold - Retrospective, Observational Register to Investigate the Procedural and Post Procedural Implantation of Bioabsorbable Magnesium Scaffolds Magmaris (MAGIC Registry)
        • Table Magmaris Bioresorbable Magnesium Scaffold - Scaffold Implantation in Emilia-Romagna
        • Table DREAMS 3G System - BIOTRONIK - Safety and Clinical Performance of the - Sirolimus-Eluting Resorbable Coronary Magnesium Scaffold System (DREAMS 3G) in the Treatment of Subjects with de Novo Lesions in Native Coronary Arteries
    • Biotronik SE & Co KG Company Overview
      • Biotronik SE & Co KG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biotronik SE & Co KG Pipeline Products & Ongoing Clinical Trials Overview
        • Table AMS-2 - Product Status
        • Table AMS-2 - Product Description
        • Table ProGenic Pimecrolimus-eluting Coronary Stent System - Product Status
        • Table ProGenic Pimecrolimus-eluting Coronary Stent System - Product Description
    • Boston Scientific Corp Company Overview
      • Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Fully Resorbable Drug-Eluting Scaffold System - Product Status
        • Table Fully Resorbable Drug-Eluting Scaffold System - Product Description
        • Table JACTAX Drug Eluting Stent - Product Status
        • Table JACTAX Drug Eluting Stent - Product Description
        • Table SYNERGY 48 Stent - Product Status
        • Table SYNERGY 48 Stent - Product Description
        • Table Synergy Megatron Bioabsorbable Polymer (BP) Stent - Product Status
        • Table Synergy Megatron Bioabsorbable Polymer (BP) Stent - Product Description
        • Table SYNERGY XD Stent - Product Status
        • Table SYNERGY XD Stent - Product Description
        • Table TAXUS Petal Bifurcation Paclitaxel-Eluting Stent System - Product Status
        • Table TAXUS Petal Bifurcation Paclitaxel-Eluting Stent System - Product Description
        • Table Boston Scientific Corp - Ongoing Clinical Trials Overview
        • Table Fully Resorbable Drug-Eluting Scaffold System - Fully Absorbable Scaffold Feasibility Study
        • Table SYNERGY 48 Stent - A Prospective Multicenter Single Arm Trial to Assess the Safety and Effectiveness of the SYNERGY 48mm Everolimus-Eluting Platinum Chromium Coronary Stent System for the Treatment of Atherosclerotic Lesion(s): EVOLVE 48
        • Table SYNERGY 48 Stent - Stent Coverage and Neointimal Tissue Characterization after Extra Long Everolimus - Eluting Stent Implantation: Prospective Study using Optical Coherence Tomography
    • Cardionovum GmbH Company Overview
      • Cardionovum GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cardionovum GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table CARDIOSORB - Product Status
        • Table CARDIOSORB - Product Description
        • Table DEBLIMUS - Product Status
        • Table DEBLIMUS - Product Description
        • Table PROTECT - Product Status
        • Table PROTECT - Product Description
        • Table ReNATURAL (M) - Product Status
        • Table ReNATURAL (M) - Product Description
        • Table ReNATURAL (P) - Product Status
        • Table ReNATURAL (P) - Product Description
    • Cardiorev Pte Ltd (Inactive) Company Overview
      • Cardiorev Pte Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cardiorev Pte Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Peptide-Eluting Coronary Stent - Product Status
        • Table Peptide-Eluting Coronary Stent - Product Description
    • Columbia University Company Overview
      • Columbia University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Columbia University Pipeline Products & Ongoing Clinical Trials Overview
        • Table C3 Exoenzyme Coated Stent - Product Status
        • Table C3 Exoenzyme Coated Stent - Product Description
    • Concept Medical Inc Company Overview
      • Concept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Concept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Abluminus DES+ - Product Status
        • Table Abluminus DES+ - Product Description
        • Table Concept Medical Inc - Ongoing Clinical Trials Overview
        • Table Abluminus DES+ - A Multicenter, Prospective, Study to Evaluate the Safety and Effcacy of the Abluminus DES+ in an All-Comers Population
        • Table Abluminus DES+ - A Post Market Registry of Abluminus Sirolimus Eluting Coronary Stent System for Percutaneous Intervention in Patients with Diabetes Mellitus
        • Table Abluminus DES+ - A Randomized Clinical Trial of Abluminus DES+ Sirolimus Eluting Stent Versus Everolimus-eluting DES for Percutaneous Coronary Intervention in Patients with Diabetes Mellitus: an Investigator-initiated Pilot Study
        • Table Abluminus DES+ - ABLUMINUS Below the Knee (BTK) Drug Eluting Stent (DES) Registry (ABLUMINUS BTK) - First in Men
        • Table Abluminus DES+ - Randomized Comparison of Abluminus DES+ Sirolimus-Eluting Stents Versus Everolimus-Eluting Stents in Coronary Artery Disease Patients with Diabetes Mellitus Global – ABILITY Diabetes Global
    • Contego Medical LLC Company Overview
      • Contego Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Contego Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table CORGUARD Coronary Stent System - Product Status
        • Table CORGUARD Coronary Stent System - Product Description
    • Cordis Corp Company Overview
      • Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Corio Pimecrolimus-eluting Stent - Product Status
        • Table Corio Pimecrolimus-eluting Stent - Product Description
        • Table CYPHER ELITE - Product Status
        • Table CYPHER ELITE - Product Description
        • Table NEVO Sirolimus-Eluting Coronary Stent - Product Status
        • Table NEVO Sirolimus-Eluting Coronary Stent - Product Description
        • Table Next Generation Coronary Stent - Product Status
        • Table Next Generation Coronary Stent - Product Description
        • Table SymBio Pimecrolimus/Paclitaxel-eluting Stent - Product Status
        • Table SymBio Pimecrolimus/Paclitaxel-eluting Stent - Product Description
    • Cytograft Tissue Engineering Inc (Inactive) Company Overview
      • Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table LifeJacket Stent Graft - Coronary Stenting - Product Status
        • Table LifeJacket Stent Graft - Coronary Stenting - Product Description
    • DISA Vascular (Pty) Ltd Company Overview
      • DISA Vascular (Pty) Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table DISA Vascular (Pty) Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Stellium Stent - Product Status
        • Table Stellium Stent - Product Description
    • Elixir Medical Corp Company Overview
      • Elixir Medical Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Elixir Medical Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table DESolve Myolimus Eluting Bioresorbable Coronary Scaffold System - Product Status
        • Table DESolve Myolimus Eluting Bioresorbable Coronary Scaffold System - Product Description
        • Table Myolimus Eluting Coronary Stent - Durable Polymer - Product Status
        • Table Myolimus Eluting Coronary Stent - Durable Polymer - Product Description
    • Envision Scientific Pvt Ltd Company Overview
      • Envision Scientific Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Envision Scientific Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Abluminus NP - Product Status
        • Table Abluminus NP - Product Description
        • Table Paclitaxel Eluting Stent - Product Status
        • Table Paclitaxel Eluting Stent - Product Description
    • HangZhou HuaAn Biotechnology Co., Ltd. Company Overview
      • HangZhou HuaAn Biotechnology Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
        • Table HangZhou HuaAn Biotechnology Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Xinsorb BRS - Product Status
        • Table Xinsorb BRS - Product Description
    • I.B.S. S.p.A. Company Overview
      • I.B.S. S.p.A. Pipeline Products & Ongoing Clinical Trials Overview
        • Table I.B.S. S.p.A. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Drug Eluting Stent - Product Status
        • Table Drug Eluting Stent - Product Description
    • Icon Interventional Systems, Inc. Company Overview
      • Icon Interventional Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Icon Interventional Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biosorb Pediatric Dissolving Stent - Product Status
        • Table Biosorb Pediatric Dissolving Stent - Product Description
    • ID Nest Medical SAS Company Overview
      • ID Nest Medical SAS Pipeline Products & Ongoing Clinical Trials Overview
        • Table ID Nest Medical SAS Pipeline Products & Ongoing Clinical Trials Overview
        • Table ID Arterial System - Product Status
        • Table ID Arterial System - Product Description
    • InspireMD Inc Company Overview
      • InspireMD Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table InspireMD Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table MGuard Drug Eluting Stent - Product Status
        • Table MGuard Drug Eluting Stent - Product Description
    • Japan Stent Technology Co., Ltd. Company Overview
      • Japan Stent Technology Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Japan Stent Technology Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bioabsorbable Stent - Product Status(Japan Stent Technology Co., Ltd.
        • Table Bioabsorbable Stent - Product Description(Japan Stent Technology Co., Ltd.)
    • JW Medical Systems Ltd Company Overview
      • JW Medical Systems Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table JW Medical Systems Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Excel II DES - Product Status
        • Table Excel II DES - Product Description
        • Table JW Medical Systems Ltd - Ongoing Clinical Trials Overview
        • Table Excel II DES - A Prospective Multicenter Randomized Trial to Assess the Safety and Effectiveness of EXCEL-II Sirolimus Eluting Stent vs. EXCEL Sirolimus Eluting Stent for the Treatment of Patients with de Novo Coronary Artery Lesions (CREDIT II Trial)
        • Table Excel II DES - A Prospective Multicenter Single-Arm Observational Registry Study to Assess the Safety and Efficacy of EXCEL-II with Sirolimus Eluting Stent for the Treatment of Patients with de Novo Coronary Artery (CREDIT-III)
    • Kaneka Corp Company Overview
      • Kaneka Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Kaneka Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table MAHOROBA Stent - Product Status
        • Table MAHOROBA Stent - Product Description
    • Kyoto Medical Planning Co Ltd Company Overview
      • Kyoto Medical Planning Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Kyoto Medical Planning Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Igaki-Tamai Coronary Stent - Product Status
        • Table Igaki-Tamai Coronary Stent - Product Description
    • Liaoning Biomedical Materials R&D Center Co Ltd Company Overview
      • Liaoning Biomedical Materials R&D Center Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Liaoning Biomedical Materials R&D Center Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table YINYI Polymer-free Drug-coated (Paclitaxel) Coronary Stent System - Product Status
        • Table YINYI Polymer-free Drug-coated (Paclitaxel) Coronary Stent System - Product Description
    • Lifetech Scientific (Shenzhen) Co Ltd Company Overview
      • Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System - Product Status
        • Table IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System - Product Description
        • Table Lifetech Scientific (Shenzhen) Co Ltd - Ongoing Clinical Trials Overview
        • Table IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System - A First-in-man Study of Sirolimus-eluting Iron Bioresorbable Coronary Scaffold System (IBS)
        • Table IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System - A Prospective, Nonrandomized, Open-label, Non-comparative, First-in-Man Study to Evaluate the Feasibility and Safety of Sirolimus-eluting Iron Bioresorbable Coronary Scaffold System
    • MangoGen Pharma Inc Company Overview
      • MangoGen Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table MangoGen Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Gene-Delivering Stent - Product Status
        • Table Gene-Delivering Stent - Product Description
    • Manli Cardiology Ltd Company Overview
      • Manli Cardiology Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Manli Cardiology Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table MIRAGE - Product Status
        • Table MIRAGE - Product Description
    • Medinol Ltd Company Overview
      • Medinol Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Medinol Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Elunir Elastomer Drug Eluting Stent - Product Status
        • Table Elunir Elastomer Drug Eluting Stent - Product Description
        • Table Elunir Elastomer Drug Eluting Stent - 38mm - Product Status
        • Table Elunir Elastomer Drug Eluting Stent - 38mm - Product Description
        • Table Elunir Elastomer Drug Eluting Stent - 44mm - Product Status
        • Table Elunir Elastomer Drug Eluting Stent - 44mm - Product Description
        • Table Medinol Ltd - Ongoing Clinical Trials Overview
        • Table Elunir Elastomer Drug Eluting Stent - BioNIR Ridaforolimus Eluting Coronary Stent System (BioNIR) EUropean Angiography Study
        • Table Elunir Elastomer Drug Eluting Stent - BioNIR Ridaforolimus Eluting Coronary Stent System (BioNIR) In Coronary Stenosis - PK Study
        • Table Elunir Elastomer Drug Eluting Stent - BioNIR Ridaforolimus Eluting Coronary Stent System (BioNIR) in Coronary Stenosis Trial
        • Table Elunir Elastomer Drug Eluting Stent - Elunir Ridaforolimus Eluting Coronary Stent System in Patients at High Bleeding Risk (HBR)- EluNIR HBR Study
        • Table Elunir Elastomer Drug Eluting Stent - Multi-center Study for Evaluating the Safety and Efficacy of the MedJ-01 Ridaforolimus Eluting Coronary Stent System (MedJ-01) In Coronary Stenosis Trial
    • Medlogics Device Corp (Inactive) Company Overview
      • Medlogics Device Corp (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Medlogics Device Corp (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table COBRA-Q Drug Eluting Stent - Product Status
        • Table COBRA-Q Drug Eluting Stent - Product Description
    • Medtronic Plc Company Overview
      • Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bifurcated Drug Eluting Stent - Product Status
        • Table Bifurcated Drug Eluting Stent - Product Description
        • Table Drug Filled Stent - Product Status
        • Table Drug Filled Stent - Product Description
        • Table Resolute Onyx DES - Bifurcation Lesions - Product Status
        • Table Resolute Onyx DES - Bifurcation Lesions - Product Description
        • Table Resolute Onyx DES - DAPT - Product Status
        • Table Resolute Onyx DES - DAPT - Product Description
        • Table Twin-Rail - Product Status
        • Table Twin-Rail - Product Description
        • Table Medtronic Plc - Ongoing Clinical Trials Overview
        • Table Resolute Onyx DES - Bifurcation Lesions - A Post-approval Study of the Medtronic Resolute Onyx Zotarolimus-eluting Coronary Stent System
        • Table Resolute Onyx DES - DAPT - A Single Arm Trial with Resolute Onyx in ONE-month DAPT for Highbleeding Risk Patients Who Are Considered One-month Clear: Onyx ONE Clear
    • Miami Cardiovascular Innovations Company Overview
      • Miami Cardiovascular Innovations Pipeline Products & Ongoing Clinical Trials Overview
        • Table Miami Cardiovascular Innovations Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biologically Engineered Stent - Product Status
        • Table Biologically Engineered Stent - Product Description
    • Micell Technologies Inc Company Overview
      • Micell Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Micell Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bioresorbable Scaffold (BRS) - Product Status
        • Table Bioresorbable Scaffold (BRS) - Product Description
        • Table MiStent SES - Product Status
        • Table MiStent SES - Product Description
        • Table Micell Technologies Inc - Ongoing Clinical Trials Overview
        • Table MiStent SES - A Prospective, Single-blinded, Multi-center, Randomized, Controlled, Registered Clinical Trial on the Efficacy and Safety of Sirolimus-eluting Stent (MiStent System) in the Treatment of Patients with Coronary Heart Disease
        • Table MiStent SES - MiStent Sirolimus Eluting Absorbable Polymer Coronary Stent System (MiStent SES) Optical Coherence Tomography (OCT)
        • Table MiStent SES - Multicenter Randomized Study of the MiStent Sirolimus Eluting Absorbable Polymer Stent System (MiStent SES) for Revascularization of Coronary Arteries
        • Table MiStent SES - Multicenter Randomized Study of the Mistent Sirolimus Eluting Absorbable Polymer Stent System (MT005) for Revascularization of Coronary Arteries
    • Michigan Technological University Company Overview
      • Michigan Technological University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Michigan Technological University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bioabsorbable Stent - Product Status
        • Table Bioabsorbable Stent - Product Description
    • MicroPort Scientific Corp Company Overview
      • MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Fantasy Drug-Eluting Stent - Product Status
        • Table Fantasy Drug-Eluting Stent - Product Description
        • Table Firebird2 Nova - Product Status
        • Table Firebird2 Nova - Product Description
        • Table Firefalcon Bioresorbable Device - Product Status
        • Table Firefalcon Bioresorbable Device - Product Description
        • Table Firesorb - Product Status
        • Table Firesorb - Product Description
        • Table MicroPort Scientific Corp - Ongoing Clinical Trials Overview
        • Table Firesorb - A First-in-man Study of the Firesorb Sirolimus Target Eluting Bioresorbable Vascular Scaffold in Patients with Coronary Artery Disease: FUTURE-I
        • Table Firesorb - A Prospective Multicenter Single-arm Clinical Trial Assessing the Safety and Effectiveness of Firesorb Sirolimus Target Eluting Bioresorbable Vascular Scaffold for the Treatment of Coronary Artery Disease: FUTURE III
        • Table Firesorb - A Randomized Trial of the Firesorb Sirolimus Target Eluting Bioresorbable Vascular Scaffold in Patients with Coronary Artery Disease: FUTURE-II
    • Minvasys SAS Company Overview
      • Minvasys SAS Pipeline Products & Ongoing Clinical Trials Overview
        • Table Minvasys SAS Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nile LM SIR Sirolimus Eluting Intracoronary Stent - Product Status
        • Table Nile LM SIR Sirolimus Eluting Intracoronary Stent - Product Description
    • MIV Therapeutics Inc Company Overview
      • MIV Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table MIV Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Smart-1 DES - Product Status
        • Table Smart-1 DES - Product Description
        • Table Smart-2 DES - Product Status
        • Table Smart-2 DES - Product Description
        • Table Smart-3 DES - Product Status
        • Table Smart-3 DES - Product Description
        • Table Smart-4 DES - Product Status
        • Table Smart-4 DES - Product Description
        • Table Vestapor - Product Status
        • Table Vestapor - Product Description
        • Table VESTAsync - Product Status
        • Table VESTAsync - Product Description
    • NanoCoeur, Inc. Company Overview
      • NanoCoeur, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table NanoCoeur, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nanocoating Cardiac Stent - Product Status
        • Table Nanocoating Cardiac Stent - Product Description
    • Nanova, Inc Company Overview
      • Nanova, Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nanova, Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Coronary Stent - Product Status
        • Table Coronary Stent - Product Description
    • National University of Ireland Galway Company Overview
      • National University of Ireland Galway Pipeline Products & Ongoing Clinical Trials Overview
        • Table National University of Ireland Galway Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cardiovascular Stent - Product Status(National University of Ireland Galway)
        • Table Cardiovascular Stent - Product Description(National University of Ireland Galway)
    • Nesstent Ltd. Company Overview
      • Nesstent Ltd. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nesstent Ltd. Pipeline Products & Ongoing Clinical Trials Overview
        • Table NesStent's Stent - Coronary Bifurcations - Product Status
        • Table NesStent's Stent - Coronary Bifurcations - Product Description
    • Nexeon MedSystems Inc Company Overview
      • Nexeon MedSystems Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nexeon MedSystems Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table PROTEX Coronary Stent System - Product Status
        • Table PROTEX Coronary Stent System - Product Description
    • North Carolina State University Company Overview
      • North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview
        • Table North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biodegradable Metal Stent - Product Status
        • Table Biodegradable Metal Stent - Product Description
    • Northwestern University Company Overview
      • Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Liquid Cast Drug-Eluting Biodegradable Stent - Product Status
        • Table Liquid Cast Drug-Eluting Biodegradable Stent - Product Description
    • NuVascular Technologies Inc Company Overview
      • NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table NuSpun DE Stent Sheath - Product Status
        • Table NuSpun DE Stent Sheath - Product Description
    • OrbusNeich Company Overview
      • OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview
        • Table OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cura Stent - Product Status
        • Table Cura Stent - Product Description
        • Table Sirolimus-Eluting Absorbable Vascular Scaffold - Product Status
        • Table Sirolimus-Eluting Absorbable Vascular Scaffold - Product Description
    • Palmaz Scientific Inc (Inactive) Company Overview
      • Palmaz Scientific Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Palmaz Scientific Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Micro-Grooved Coronary Stent - Product Status
        • Table Micro-Grooved Coronary Stent - Product Description
    • Pediastent LLC Company Overview
      • Pediastent LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Pediastent LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Pediatric Bioresorbable Stent - Product Status
        • Table Pediatric Bioresorbable Stent - Product Description
    • QualiMed Innovative Medizinprodukte GmbH Company Overview
      • QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biodegradable Coronary Stent - Product Status
        • Table Biodegradable Coronary Stent - Product Description
    • Qvanteq AG Company Overview
      • Qvanteq AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Qvanteq AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Qstent Coronary Stent System - Product Status
        • Table Qstent Coronary Stent System - Product Description
    • Relisys Medical Devices Ltd Company Overview
      • Relisys Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Relisys Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Corel + C Drug Eluting Stent - Product Status
        • Table Corel + C Drug Eluting Stent - Product Description
    • REVA Medical Inc Company Overview
      • REVA Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table REVA Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold - Product Status
        • Table Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold - Product Description
        • Table ReZolve Sirolimus-Eluting Bioresorbable Coronary Scaffold - Product Status
        • Table ReZolve Sirolimus-Eluting Bioresorbable Coronary Scaffold - Product Description
        • Table ReZolve2 Drug Eluting Bioresorbable Coronary Scaffold - Product Status
        • Table ReZolve2 Drug Eluting Bioresorbable Coronary Scaffold - Product Description
        • Table REVA Medical Inc - Ongoing Clinical Trials Overview
        • Table ReZolve Sirolimus-Eluting Bioresorbable Coronary Scaffold - Pilot Study of the Rezolve Sirolimuseluting Bioresorbable Coronary Stent
        • Table ReZolve2 Drug Eluting Bioresorbable Coronary Scaffold - Safety And Performance Study Of The ReZolve2 Sirolimus-Eluting Bioresorbable Coronary Scaffold (RESTORE II Trial)
        • Table Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold - Expanded FANTOM II Clinical Study
        • Table Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold - Pilot Study of the REVA Sirolimus- Eluting Bioresorbable Coronary Scaffold
        • Table Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold - Post Market Study of the FANTOM Sirolimus-eluting Bioresorbable Coronary Scaffold
        • Table Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold - Safety and Performance Study of the FANTOM Sirolimus-eluting Bioresorbable Coronary Scaffold
        • Table Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold - Vascular Healing Pattern, Vasoreactivity, and Quality of Life in Patients with ST Segment Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention with Sirolimus Eluting FANTOM Bioresorbable Vascular Scaffold with Long Term Clinical, Near Infrared Spectroscopy and Optical Coherence Tomography Follow-up: A FANTOM STEMI Pilot Study
    • Rontis AG Company Overview
      • Rontis AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Rontis AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bifurcation Stent System - Product Status
        • Table Bifurcation Stent System - Product Description
    • S3V Vascular Technologies Company Overview
      • S3V Vascular Technologies Pipeline Products & Ongoing Clinical Trials Overview
        • Table S3V Vascular Technologies Pipeline Products & Ongoing Clinical Trials Overview
        • Table 3V Avatar - Product Status
        • Table 3V Avatar - Product Description
    • Sahajanand Medical Technologies Pvt Ltd Company Overview
      • Sahajanand Medical Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sahajanand Medical Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Next-Generation Stent - Product Status
        • Table Next-Generation Stent - Product Description
    • Shanghai Bio-heart Biological Technology Co Ltd Company Overview
      • Shanghai Bio-heart Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Shanghai Bio-heart Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table BioheartRapamycin Drug-Eluting Bioresorbable Coronary Stent System - Product Status
        • Table BioheartRapamycin Drug-Eluting Bioresorbable Coronary Stent System - Product Description
        • Table Shanghai Bio-heart Biological Technology Co Ltd - Ongoing Clinical Trials Overview
        • Table BioheartRapamycin Drug-Eluting Bioresorbable Coronary Stent System - A Randomized Controlled Trial of the Bioheart Rapamycin Drug-Eluting Bioresorbable Coronary Stent System in Patients With Coronary Artery Disease: BIOHEART-II
        • Table BioheartRapamycin Drug-Eluting Bioresorbable Coronary Stent System - A Registry Trial of the Bioheart Rapamycin Drug-eluting Bioresorbable Coronary Stent System in Patients with Coronary Artery Disease: BIOHEART III
    • Sino Medical Sciences Technology Inc Company Overview
      • Sino Medical Sciences Technology Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sino Medical Sciences Technology Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table BuMA Supreme DES - Product Status
        • Table BuMA Supreme DES - Product Description
        • Table Sino Medical Sciences Technology Inc - Ongoing Clinical Trials Overview
        • Table BuMA Supreme DES - A Prospective Global Randomized Trial Assessing the Safety and Efficacy of the BuMA Supreme Biodegradable Drug Coated Coronary Stent System for Coronary Revascularization in Patients with Stable Coronary Artery Disease or Non-ST Segment Elevation Acute Coronary Syndromes
        • Table BuMA Supreme DES - A Prospective, Multicenter First-in-man Trial Program in China to Evaluate the Efficacy and Safety of Buma Supreme (Eg Grafting) Biodegradable Polymer Sirolimus Eluting Stent in Subjects with De Novo Coronary Lesions, RCT Trial
        • Table BuMA Supreme DES - A Prospective, Multicenter Trial Program in China to Evaluate the Efficacy and Safety of BuMA Supreme (eG Grafting) Biodegradable Polymer Sirolimus Eluting Stent in Patients with de Novo Coronary Lesions, OPC Trial
        • Table BuMA Supreme DES - A Prospective, Multicenter, Randomized Comparative Evaluation of BuMA Supreme Stent and of Xience Stent in Terms of the Extent of Neointimal Formation at 1 Month and 2 Months Via OCT After Implantation in High Bleeding Risk CAD Patients: PIONEER-II OCT Study
    • Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
      • Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bare Metal Coronary Stent - Product Status
        • Table Bare Metal Coronary Stent - Product Description
        • Table TiN-coated Coronary Stent - Product Status
        • Table TiN-coated Coronary Stent - Product Description
    • Stentys SA Company Overview
      • Stentys SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Stentys SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table STENTYS Paclitaxel-Eluting Stent - Product Status
        • Table STENTYS Paclitaxel-Eluting Stent - Product Description
    • Svelte Medical Systems Inc Company Overview
      • Svelte Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Svelte Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table DIRECT RX - Product Status
        • Table DIRECT RX - Product Description
        • Table SLENDER IDS - Product Status
        • Table SLENDER IDS - Product Description
        • Table Svelte Medical Systems Inc - Ongoing Clinical Trials Overview
        • Table SLENDER IDS - OPTIMIZE Sirolimus-eluting Coronary Stent Systems Pharmacokinetics (PK) Study
        • Table SLENDER IDS - The OPTIMIZE Trial to Assess the Procedural and Clinical Value of the Svelte IDS and RX Sirolimus Eluting Coronary Stent Systems for the Treatment of Atherosclerotic Lesions in a Randomized Study
        • Table DIRECT RX - OPTIMIZE Sirolimus-eluting Coronary Stent Systems Pharmacokinetics (PK) Study
        • Table DIRECT RX - The OPTIMIZE Trial to Assess the Procedural and Clinical Value of the Svelte IDS and RX Sirolimus Eluting Coronary Stent Systems for the Treatment of Atherosclerotic Lesions in a Randomized Study
    • Tepha Inc Company Overview
      • Tepha Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Tepha Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table TephaFLEX Absorbable Coronary Stent - Product Status
        • Table TephaFLEX Absorbable Coronary Stent - Product Description
    • Terumo Corp Company Overview
      • Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Next Generation Drug Eluting Bioresorbable Scaffold - Product Status
        • Table Next Generation Drug Eluting Bioresorbable Scaffold - Product Description
        • Table Next Metallic Drug Eluting Stent - Product Status
        • Table Next Metallic Drug Eluting Stent - Product Description
        • Table Ultimaster Tansei - Product Status
        • Table Ultimaster Tansei - Product Description
        • Table Terumo Corp - Ongoing Clinical Trials Overview
        • Table Ultimaster Tansei - 3-month Discontinuation of Dual Antiplatelet Therapy after Ultimaster Sirolimus-eluting Stent Implantation
        • Table Ultimaster Tansei - A Prospective Study, Single-arm, Multicenter, Observational to Evaluate Safety and Effectiveness of Stent Ultimaster Tansei Coronary Stent in Complex Coronary Lesions
        • Table Ultimaster Tansei - Comparison of the Supraflex Cruz 60 Micron Stent Strut Versus the Ultimaster Tansei 80 Micron Stent Strut in High Bleeding Risk PCI Population
        • Table Ultimaster Tansei - Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation with an Abbreviated Versus Prolonged DAPT Regimen
    • TissueGen Inc Company Overview
      • TissueGen Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table TissueGen Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cardiovascular Stent - Product Status
        • Table Cardiovascular Stent - Product Description
    • TrendyMED Inc. Company Overview
      • TrendyMED Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table TrendyMED Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Over and Under Pericardium Covered Stent - Product Status
        • Table Over and Under Pericardium Covered Stent - Product Description
    • University of Alabama at Birmingham Company Overview
      • University of Alabama at Birmingham Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Alabama at Birmingham Pipeline Products & Ongoing Clinical Trials Overview
        • Table Endothelium Nanomatrix Coated Stent - Product Status
        • Table Endothelium Nanomatrix Coated Stent - Product Description
    • University of Colorado Company Overview
      • University of Colorado Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Colorado Pipeline Products & Ongoing Clinical Trials Overview
        • Table SMP Arterial Stent - Product Status
        • Table SMP Arterial Stent - Product Description
    • University of Florida Company Overview
      • University of Florida Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Florida Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nanocomposite Drug Eluting Stent - Product Status
        • Table Nanocomposite Drug Eluting Stent - Product Description
    • University of Michigan Company Overview
      • University of Michigan Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Michigan Pipeline Products & Ongoing Clinical Trials Overview
        • Table Antenna Integrated Coronary Stent - Product Status
        • Table Antenna Integrated Coronary Stent - Product Description
    • University of Strathclyde Company Overview
      • University of Strathclyde Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Strathclyde Pipeline Products & Ongoing Clinical Trials Overview
        • Table Drug-Eluting Stent - Product Status
        • Table Drug-Eluting Stent - Product Description
        • Table Magnesium Alloy Stent - Product Status
        • Table Magnesium Alloy Stent - Product Description
    • University of Utah Company Overview
      • University of Utah Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Utah Pipeline Products & Ongoing Clinical Trials Overview
        • Table Pressure Sensing Stent - Product Status
        • Table Pressure Sensing Stent - Product Description
    • VasoTech Inc. Company Overview
      • VasoTech Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table VasoTech Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table PowerStent Absorb DES - Product Status
        • Table PowerStent Absorb DES - Product Description
        • Table PowerStent Coro DES - Product Status
        • Table PowerStent Coro DES - Product Description
    • Viller Scientific LLC Company Overview
      • Viller Scientific LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Viller Scientific LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table VILLER Stent System - Product Status
        • Table VILLER Stent System - Product Description
    • Vornia Biomaterials Ltd Company Overview
      • Vornia Biomaterials Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vornia Biomaterials Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vornia Camouflage Stent - Product Status
        • Table Vornia Camouflage Stent - Product Description
    • Xenogenics Corporation Company Overview
      • Xenogenics Corporation Pipeline Products & Ongoing Clinical Trials Overview
        • Table Xenogenics Corporation Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ideal BioStent - First Generation - Product Status
        • Table Ideal BioStent - First Generation - Product Description
        • Table Ideal BioStent - Second Generation - Product Status
        • Table Ideal BioStent - Second Generation - Product Description
        • Table Whisper Coronary Stent System - Product Status
        • Table Whisper Coronary Stent System - Product Description
  • Coronary Stents- Recent Developments
    • Sep 17, 2020: CIRSE 2020: New clinical data support use of 4-french devices for ambulatory pad treatment
    • Jul 28, 2020: Impressio and MedShape awarded competitive grant from the National Science Foundation to develop joint replacement device
    • Jun 15, 2020: MicroPort announces strategic investment and forms joint venture with Indian medical device company purple medical
    • May 15, 2020: Microport orthopedics group brings in new strategic investors
    • May 14, 2020: Study examines the safety of bioabsorbable polymer against durable polymer drug-eluting stents in high-risk patients undergoing percutaneous coronary intervention
    • May 13, 2020: Truleaf Medical's successful mitral valve replacement large animals clinical trial proves the accurate deployment and long-term functioning of the implants in the heart
    • Apr 16, 2020: Abbott reports first-quarter 2020 results
    • Apr 14, 2020: BioCardia announces litigation financing in the case captioned Boston Scientific
    • Feb 24, 2020: BIOTRONIK's Ultrathin Strut Orsiro Coronary Drug-Eluting Stent continues to deliver excellent results after three years
    • Feb 24, 2020: Merit Medical reports earnings for fourth quarter and year ended December 31, 2019, gives FY 2020 Guidance
    • Feb 24, 2020: 2020 Catalyst Award Winner Medtronic hires Chief Inclusion and Diversity Officer
    • Feb 18, 2020: Medtronic reports third quarter financial results 2020
    • Feb 14, 2020: Vascular Perspectives and Asahi Intecc form strategic alliance.
    • Feb 12, 2020: BIOTRONIK introduces next generation Drug-Eluting Stent System in the CE region
    • Feb 11, 2020: Abbott Laboratories: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officer
    • Feb 05, 2020: Boston Scientific announces results for fourth quarter and full year 2019
    • Feb 05, 2020: Surmodics reports first quarter Fiscal 2020 results
    • Feb 03, 2020: Surmodics names Nusrath Sultana, MD, as Vice President, Clinical Affairs
    • Jan 27, 2020: Merit Medical issues statement regarding director nominations from starboard
    • Jan 22, 2020: ANGIOLITE trial 2 years outcomes have been published at EuroIntervention
    • Jan 22, 2020: Abbott reports fourth-quarter 2019 results; announces strong forecast for 2020
    • Jan 15, 2020: Merit milestones: facilities in Galway and Tijuana reach 1,000 employees
    • Jan 14, 2020: Boston Scientific announces preliminary unaudited sales for the fourth quarter and full year 2019
    • Jan 14, 2020: ICON issues financial guidance for full year 2020
    • Jan 08, 2020: ABBOTT LABORATORIES: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers.
    • Dec 20, 2019: Cook Medical applauds congressional action to repeal the medical device excise tax
    • Dec 20, 2019: Osprey Medical: Fourth Quarter Update
    • Dec 12, 2019: Notice regarding establishment of Overseas Sales Subsidiary Asahi Intecc CIS
    • Dec 04, 2019: Lumeon and Medtronic partner to deliver new models of care in Europe
    • Nov 27, 2019: Enrolment completed for MASTER DAPT, a landmark trial investigating abbreviated DAPT post-implantation of Terumo's Ultimaster DES in high bleeding risk patients
    • Nov 27, 2019: Indian stent-maker SMT acquires majority stake in Zarek
    • Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019
    • Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report
    • Nov 13, 2019: Abbott announces Robert B. Ford to Succeed Miles D. White as Chief Executive Officer on March 31, 2020
    • Nov 12, 2019: Cook Medical's leadership updates in Asia-pacific reinforce focus on growth and physician relationships
    • Nov 06, 2019: Final five unpublished late-breaking clinical trial results announced at VIVA19
    • Oct 31, 2019: Surmodics reports fourth quarter fiscal 2019 results and issues fiscal 2020 revenue and EPS Guidance
    • Oct 30, 2019: Orsiro Coronary Drug-Eluting Stent receives market approval in China
    • Oct 30, 2019: Merit Medical reports earnings for third quarter of 2019
    • Oct 29, 2019: Osprey Medical: 48% increase in DyeVert third quarter unit sales
    • Oct 28, 2019: PolyNovo: Appointment non-executive director – Dr Robyn Elliott
    • Oct 23, 2019: ICON reports third quarter 2019 results
    • Oct 23, 2019: Boston Scientific announces results for third quarter 2019
    • Oct 23, 2019: Edwards Lifesciences reports third quarter results
    • Oct 21, 2019: Sean Salmon named executive vice president and group president of Medtronic Diabetes
    • Oct 16, 2019: Abbott reports third-quarter 2019 results
    • Oct 14, 2019: STENTYS: 2019 half-year results
    • Oct 10, 2019: CINDE announces Edwards Lifesciences invests $100 million to expand its operations in Costa Rica
    • Oct 09, 2019: ASAHI INTECC announces opening of medical components website of EU branch
    • Oct 08, 2019: Paclitaxel-coated devices are safe for unblocking arteries in lower limbs
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook